Campaign launched during World Health Assembly, where world’s health ministers gather to address the large physical and economic costs of these disorders Mental and neurological disorders (MNDs) affect 700 million people annually and account for 30 percent of global non-communicable disease (NCD) burden ‘Do You Mind?’ helps patients, family members, policymakers and others to understand...
Read moreToday we celebrate the World Intellectual Property Day to praise the invaluable contributions made by innovators across the globe. Since the dawn of time, mankind has applied innovation to solve problems and live better, healthier and more plentiful lives. Apart from human creativity and passion, IP has been one of the most powerful forces fostering...
Read moreUNODC Commission on Crime Prevention and Criminal Justice, 22nd session IFPMA statement under item 7 of the provisional agenda on World crime trends and emerging issues and responses in the field of crime prevention and criminal justice Countering fraudulent medicines, in particular their trafficking Delivered by Cyntia Genolet, Policy Analyst, Public Affairs and Global Health...
Read moreResults from the UN Decade to Roll Back Malaria tell us global malaria deaths have been reduced by 38% and that 10 countries on the African continent—and most endemic countries in other regions—halved malaria cases and deaths. This means the lives of 1.1 million children under five years have been saved in the last decade....
Read morePeer-reviewed article in Vaccine addresses the 4As of vaccine access – availability, affordability, adoption and alliances Paper’s recommendations offer insights on how to achieve the Decade of Vaccine’s goal of 90% global vaccine coverage by 2020. Increased vaccine awareness, predictable demand, and sustainable financing among 26 expert recommendations to support vaccine access and innovation A...
Read moreIncremental innovation is the term used for subsequent improvements made to a “first-in-class” medicine, but it is often incorrectly associated with prolonging the patent term for an existing medicine which is not the case. Indeed, once the patent exclusivity period of the existing “first-in-class” patent has expired, any firm, regardless of patenting related to improvements...
Read more